140 related articles for article (PubMed ID: 3433275)
1. Guanidino compounds in hyperargininemia.
Mizutani N; Hayakawa C; Ohya Y; Watanabe K; Watanabe Y; Mori A
Tohoku J Exp Med; 1987 Nov; 153(3):197-205. PubMed ID: 3433275
[TBL] [Abstract][Full Text] [Related]
2. Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy.
Marescau B; Qureshi IA; De Deyn P; Letarte J; Ryba R; Lowenthal A
Clin Chim Acta; 1985 Feb; 146(1):21-7. PubMed ID: 3987036
[TBL] [Abstract][Full Text] [Related]
3. Guanidino compound analysis as a complementary diagnostic parameter for hyperargininemia: follow-up of guanidino compound levels during therapy.
Marescau B; De Deyn PP; Lowenthal A; Qureshi IA; Antonozzi I; Bachmann C; Cederbaum SD; Cerone R; Chamoles N; Colombo JP
Pediatr Res; 1990 Mar; 27(3):297-303. PubMed ID: 1690873
[TBL] [Abstract][Full Text] [Related]
4. Increased plasma and tissue guanidino compounds in a mouse model of hyperargininemia.
Deignan JL; Marescau B; Livesay JC; Iyer RK; De Deyn PP; Cederbaum SD; Grody WW
Mol Genet Metab; 2008 Feb; 93(2):172-8. PubMed ID: 17997338
[TBL] [Abstract][Full Text] [Related]
5. Guanidino compounds that are increased in hyperargininemia inhibit GABA and glycine responses on mouse neurons in cell culture.
De Deyn PP; Marescau B; Macdonald RL
Epilepsy Res; 1991 Mar; 8(2):134-41. PubMed ID: 1712285
[TBL] [Abstract][Full Text] [Related]
6. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
Levillain O; Marescau B; de Deyn PP
Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
[TBL] [Abstract][Full Text] [Related]
7. Enzyme replacement therapy in a patient with hyperargininemia.
Mizutani N; Hayakawa C; Maehara M; Watanabe K
Tohoku J Exp Med; 1987 Mar; 151(3):301-7. PubMed ID: 3590176
[TBL] [Abstract][Full Text] [Related]
8. Excretion of guanidino-derivates in urine of hyperargininemic patients.
Wiechert P; Mortelmans J; Lavinha F; Clara R; Terheggen HG; Lowenthal A
J Genet Hum; 1976 Mar; 24(1):61-72. PubMed ID: 819629
[TBL] [Abstract][Full Text] [Related]
9. Dehydration modifies guanidino compound concentrations in the different zones of the rat kidney.
Levillain O; Marescau B; Possemiers I; De Deyn P
Pflugers Arch; 2002 May; 444(1-2):143-52. PubMed ID: 11976926
[TBL] [Abstract][Full Text] [Related]
10. Hyperargininemia, epilepsy and the metabolism of guanidino compounds.
Wiechert P; Marescau B; De Deyn PP; Lowenthal A
Padiatr Grenzgeb; 1989; 28(2):101-6. PubMed ID: 2657590
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of Na+,K(+)-ATPase activity from rat cerebral cortex by guanidino compounds accumulating in hyperargininemia.
da Silva CG; Parolo E; Streck EL; Wajner M; Wannmacher CM; Wyse AT
Brain Res; 1999 Aug; 838(1-2):78-84. PubMed ID: 10446319
[TBL] [Abstract][Full Text] [Related]
12. Guanidino compound levels in brain regions of non-dialyzed uremic patients.
De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C
Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461
[TBL] [Abstract][Full Text] [Related]
13. Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction.
Verhelst J; Berwaerts J; Marescau B; Abs R; Neels H; Mahler C; De Deyn PP
Metabolism; 1997 Sep; 46(9):1063-7. PubMed ID: 9284897
[TBL] [Abstract][Full Text] [Related]
14. Guanidino compound levels in blood, cerebrospinal fluid, and post-mortem brain material of patients with argininemia.
Deignan JL; De Deyn PP; Cederbaum SD; Fuchshuber A; Roth B; Gsell W; Marescau B
Mol Genet Metab; 2010; 100 Suppl 1():S31-6. PubMed ID: 20176499
[TBL] [Abstract][Full Text] [Related]
15. Use of enzyme-loaded erythrocytes in in-vitro correction of arginase-deficient erythrocytes in familial hyperargininemia.
Adriaenssens K; Karcher D; Lowenthal A; Terheggen HG
Clin Chem; 1976 Mar; 22(3):323-6. PubMed ID: 1253407
[TBL] [Abstract][Full Text] [Related]
16. Arginase deficiency in multiple tissues in argininemia.
Michels VV; Beaudet AL
Clin Genet; 1978 Jan; 13(1):61-7. PubMed ID: 624188
[TBL] [Abstract][Full Text] [Related]
17. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
[TBL] [Abstract][Full Text] [Related]
18. Absence of erythrocyte arginase protein in Japanese patients with hyperargininemia.
Hayakawa C; Aono S; Keino H; Mizutani N; Watanabe K; Ikemoto M; Totani M; Murachi T; Kashiwamata S
Eur J Pediatr; 1991 Sep; 150(11):800-3. PubMed ID: 1959545
[TBL] [Abstract][Full Text] [Related]
19. Excretion of alpha-keto-delta-guanidinovaleric acid and its cyclic form in patients with hyperargininemia.
Marescau B; Pintens J; Lowenthal A; Terheggen HG
Clin Chim Acta; 1979 Oct; 98(1-2):35-8. PubMed ID: 498528
[TBL] [Abstract][Full Text] [Related]
20. In vitro stimulation of oxidative stress in cerebral cortex of rats by the guanidino compounds accumulating in hyperargininemia.
Wyse AT; Bavaresco CS; Hagen ME; Delwing D; Wannmacher CM; Severo Dutra-Filho C; Wajner M
Brain Res; 2001 Dec; 923(1-2):50-7. PubMed ID: 11743972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
